![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/06\/4000-cb2-insights.jpg\")
<\/p>\n<\/p>\n
CB2 Insights one of the largest integrative healthcare systems in the United States, is pleased to provide the following corporate update and outlook on growth for 2020 and 2021. CB2 Insights Inc. is a US-focused, healthcare services and technology company. The Company owns and operates a proprietary virtual telehealth platform and a network of over 30 medical clinics across 12 states in the US, providing integrative, primary and urgent care services since 2017 to over 100,000 patients annually.<\/p>\n
The Company is positioning itself to become one of the largest national networks of health centers in the US powered by technology and telemedicine delivery mechanisms. Its fast-growing customer base will aim to reach millions in the coming years as they continue to expand on services for both insured and uninsured segments of the US population. CB2’s revenue stream will be driven by membership subscription revenue and insurable services through traditional insurance payors, most notably Medicare and Medicaid, in both traditional bricks-and mortar clinics, and a proprietary virtual telemedicine offering.<\/p>\n
CB2 is led by a strong management team with over 50 years of collective experience in clinical practice management, technology and primary care in both the Canadian and US healthcare market. Further, it is well positioned to execute against its strategy. In Q2 2020, it announced positive EBITDA and free cash flow for the very first time – a trend that has continued into Q3 2020. It also recently strengthened its balance sheet with a $5.13 million upsized and oversubscribed private placement, bringing total cash in the company to over $6 million.<\/p>\n
The Company’s growth will be focused on a 3-pronged strategic plan generating strong results both organically and through targeted, accretive M&A activity.<\/p>\n
Prad Sekar, Chief Executive Officer of CB2 commented “This is the right time for this aggressive growth strategy. We have the management expertise, capital and infrastructure to execute against our 3-pronged plan. In the coming months, shareholders can expect to see continued newsflow to support our growth model. Over the last 12 months, we have focused on successfully reaching profitability. We now fully anticipate such growth to accelerate as we move toward this exciting future.”<\/p>\n
About CB2 Insights<\/strong><\/p>\n CB2 Insights is a healthcare services and technology company, working to positively impact patient health outcomes. The Companies mission to improve the lives of patients through the prevention and treatment of health conditions and using proprietary technology to monitor, assess, and generate insights to help improve patient outcomes. The Company owns and operates a proprietary virtual telehealth platform, and a network of over 30 medical clinics across 12 states in the US, providing integrative, primary and urgent care services to over 100,000 patients annually.<\/p>\n The Company has created works primarily to roster and treat patients seeking traditional and alternative treatments due to the ineffectiveness of conventional medicine, lnability to find support through their existing care network, or in some cases, inability to access a primary care network. The Company offers both primary care via a traditional insurable services model and a disruptive low-cost subscription based urgent care offering for patients seeking immediate need to a healthcare provider via telehealth.<\/p>\n The Company differentiates itself by being one of the largest integrative medical practices in the US that owns its own proprietary technology, data analytical assets, and clinical research expertise to support new market expansion, market access, data collection and analysis and drug discovery.<\/p>\n The Company operates a proprietary electronic health record platform Sail (“Sail”) to document, treat, monitor and report on patient health outcomes. Developed in 2015, Sail is used internally across all of the Company’s clinical operations. Sail features a robust telemedicine platform that the Company uses to provide care to its National patient base. To support patient care and positive health outcomes, the Company is also focused on advancing safety and efficacy research surrounding alternative health treatments by monitoring and assessing Real-World Data (RWD) and providing Real-World Evidence (RWE) through our proprietary technology, data analytics, and a full service contract research organization.<\/p>\n For more information please visit www.cb2insights.com.<\/p>\n Tags:<\/b> Investor RelationsFor more information please contact:\r\n\r\nInvestor Relations\r\nJonathan L. Robinson CFA\r\nOak Hill Financial\r\n\r\n416-669-1001<\/pre>\n
See Campaign: <\/strong>http:\/\/www.cb2insights.com<\/a>
Contact Information:<\/b>
Investor Relations
\nJonathan L. Robinson CFA
\nOak Hill Financial
\n416-669-1001<\/p>\n
<\/a>, Wire<\/a>, Disclosure Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nJonathan L. Robinson CFA
\nOak Hill Financial
\n416-669-1001<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"CB2 Insights one of the largest integrative healthcare systems in the United States, is pleased to provide the following corporate update and outlook on growth for 2020 and 2021. CB2 Insights Inc. is a US-focused, healthcare services and technology company. The Company owns and operates a proprietary virtual telehealth platform and a network of over … Continue reading CB2 Insights Offers Primary Care Services via Telehealth to Over 100,000 patients across 12 US States<\/span><\/a> Continue Reading